M. Vogel

发表

Dutch genome diagnostic laboratories accelerated and improved variant interpretation and increased accuracy by sharing data

Jeroen F. J. Laros, R. Pfundt, G. Thijs, 2019, Human mutation.

Detection of in vivo protein–DNA interactions using DamID in mammalian cells

Bas van Steensel, B. Steensel, M. Vogel, 2007, Nature Protocols.

Human heterochromatin proteins form large domains containing KRAB-ZNF genes.

Ben Abbas, B. van Steensel, Anne-Kathrin Classen, 2006, Genome research.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

Best Practice Guidelines for the Use of Next‐Generation Sequencing Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome Diagnostic Laboratories

Quinten Waisfisz, M. Nelen, Q. Waisfisz, 2013, Human mutation.

Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects

Edwin Cuppen, Marcel Nelen, Wilfred F J van IJcken, 2015, European Journal of Human Genetics.

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

W. V. van Harten, P. Nederlof, M. Vogel, 2016, Ecancermedicalscience.

Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics

B. Tops, E. Schuuring, P. Nederlof, 2019, Virchows Archiv.

High-resolution mapping of heterochromatin redistribution in a Drosophila position-effect variegation model

B. van Steensel, L. Pagie, M. Vogel, 2009, Epigenetics & Chromatin.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Ablepharon macrostomia syndrome: A distinct genetic entity clinically related to the group of FRAS–FREM complex disorders

E. Zackai, C. Stevens, F. Brancati, 2013, American journal of medical genetics. Part A.

Discovery of variants unmasked by hemizygous deletions

E. Cuppen, R. Hochstenbach, M. Poot, 2012, European Journal of Human Genetics.

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

W. Chung, F. Couch, O. Olopade, 2021, Genetics in Medicine.

Mutations in GRIP1 cause Fraser syndrome

P. Scambler, M. Vogel, E. Blair, 2012, Journal of Medical Genetics.

Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects

J. Veltman, E. Cuppen, R. Hennekam, 2015, European Journal of Human Genetics.

Fraser syndrome without cryptophthalmos: Two cases.

B. van der Zwaag, M. Vogel, S. Lyonnet, 2020, European journal of medical genetics.

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Communications.

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

F. Couch, A. Spurdle, M. Southey, 2024, medRxiv.

Ablepharon macrostomia syndrome: A distinct genetic entity clinically related to the group of FRAS–FREM complex disorders

E. Zackai, C. Stevens, F. Brancati, 2013, American journal of medical genetics. Part A.